Cirrhosis News and Research

Latest Cirrhosis News and Research

Non-alcoholic fatty liver disease linked to higher risk of blood clots in healthy adults

Recent study in Scientific Reports finds a link between nonalcoholic fatty liver disease (NAFLD) and a higher risk of venous thromboembolism (VTE) among healthy Korean adults. The research suggests that NAFLD may contribute to a hypercoagulable state, increasing the risk of VTE.

27 Sep 2023

Genetic markers could help identify people at risk for metabolic dysfunction-associated steatotic liver disease

An astounding 30% of Americans currently have metabolic dysfunction-associated steatotic liver disease, or MASLD, which is formerly known as nonalcoholic fatty liver disease, or NAFLD.

27 Sep 2023

Living donor liver transplantation improves waitlist outcomes in high-risk cirrhosis patients

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 17, entitled, "Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients."

26 Sep 2023

Is menopausal hormone therapy associated with non-alcoholic fatty liver disease?

The effects of menopausal hormone therapy on non-alcoholic fatty liver disease.

21 Sep 2023

Eating your greens could trump genetics in fighting fatty liver disease, new study suggests

A recent longitudinal study using data from the U.K. Biobank explores the interplay between plant-based diets and genetic predisposition in affecting the risk of non-alcoholic fatty liver disease (NAFLD). The study finds that a higher consumption of healthful plant-based foods can mitigate the risk of NAFLD, even in individuals with genetic susceptibility, while unhealthful plant-based foods increase the risk.

19 Sep 2023

Coffee, fiber, and the Mediterranean diet are key players in fighting nonalcoholic fatty liver disease

Dietary patterns, foods, and nutrients to ameliorate nonalcoholic fatty liver disease (NAFLD).

19 Sep 2023

First-degree relatives of patients with MASLD have higher risk of developing liver-related diseases

Close relatives of people with metabolic-associated fatty liver disease have a higher risk of developing liver cancer and dying from liver-related diseases, according to a national study from Karolinska Institutet in Sweden published in The Journal of Hepatology.

8 Sep 2023

Hepatitis C patients may benefit from revaccination against hepatitis B after treatment

Recently published research from the University of Minnesota Medical School suggests individuals with hepatitis C should consider revaccination for hepatitis B. The study was published in the Journal of Infectious Diseases.

8 Sep 2023

Exploring the role of the metabolic syndrome in individual mechanisms of liver fibrosis

Chronic liver injury results in the development of liver fibrosis in approximately 25% of individuals in response to diverse insults, and several aspects of the development of liver injury appear to be common to a variety of initiating factors.

31 Aug 2023

Inorganic nitrate reduces contrast-induced nephropathy in high-risk patients

Inorganic nitrate reduces contrast-induced nephropathy (CIN), improves renal outcomes and reduces cardiac events compared to placebo in patients at risk of renal injury undergoing coronary angiography for acute coronary syndrome, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

Non-alcoholic steatohepatitis progression blocked by ginger essential oil

Researchers explore the potential utility of ginger essential oil in preventing NASH.

29 Aug 2023

High cost of hepatic encephalopathy treatment may lead to medication non-adherence

Researchers from the University of Minnesota Medical School and College of Pharmacy have found that high costs for hepatic encephalopathy treatment in patients with end-stage liver disease were associated with decreased treatment retention for patients.

25 Aug 2023

$9.57 million grant will support a clinical trial to study new treatment option for NAFLD

According to the National Institutes of Health, approximately 24% of adults in the United States have nonalcoholic fatty liver disease (NAFLD), an umbrella term for a range of liver conditions affecting people who drink little to no alcohol that can lead to cirrhosis, liver cancer and liver failure.

23 Aug 2023

Study identifies an endogenous bile acid that alleviates non-alcoholic fatty liver disease

A study finds that hyodeoxycholic acid alleviates non-alcoholic fatty liver disease by modulating the gut-liver axis.

22 Aug 2023

AI-based model indicates chest radiography as a potential biomarker of aging

A recent study developed an AI model to determine the age of individuals by analyzing chest radiographs.

21 Aug 2023

Meta-analysis reports global prevalence of MAFLD of 38.8% in adults

Non-alcoholic fatty liver disease (NAFLD) is a common condition that affects up to 30% of adults in the general population.

18 Aug 2023

Sugar-sweetened beverages linked to increased risk of liver cancer and chronic liver disease mortality

Approximately 65% of adults in the United States consume sugar sweetened beverages daily. Chronic liver disease is a major cause of morbidity and mortality worldwide and can result in liver cancer and liver disease-related mortality.

8 Aug 2023

Hepatitis C treatment initiation found to be low among Medicaid recipients

While there are highly effective treatments for the hepatitis C virus (HCV), only 1 in 5 Medicaid enrollees diagnosed with HCV started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University's Ithaca campus.

8 Aug 2023

Hepatitis C cure still linked to higher mortality rates

Individuals who have been cured of hepatitis C infection still face a substantially greater risk of death compared with the general population - between 3 and 14 times higher depending on liver disease stage, finds the largest study of its kind published by The BMJ today.

2 Aug 2023

Is there an association between alcohol consumption and blood pressure levels?

The dose-response association between alcohol consumption and blood pressure (BP) levels.

2 Aug 2023

Cirrhosis News and Research

Latest Cirrhosis News and Research

Non-alcoholic fatty liver disease linked to higher risk of blood clots in healthy adults

Genetic markers could help identify people at risk for metabolic dysfunction-associated steatotic liver disease

Living donor liver transplantation improves waitlist outcomes in high-risk cirrhosis patients

Is menopausal hormone therapy associated with non-alcoholic fatty liver disease?

Eating your greens could trump genetics in fighting fatty liver disease, new study suggests

Coffee, fiber, and the Mediterranean diet are key players in fighting nonalcoholic fatty liver disease

First-degree relatives of patients with MASLD have higher risk of developing liver-related diseases

Hepatitis C patients may benefit from revaccination against hepatitis B after treatment

Exploring the role of the metabolic syndrome in individual mechanisms of liver fibrosis

Inorganic nitrate reduces contrast-induced nephropathy in high-risk patients

Non-alcoholic steatohepatitis progression blocked by ginger essential oil

High cost of hepatic encephalopathy treatment may lead to medication non-adherence

$9.57 million grant will support a clinical trial to study new treatment option for NAFLD

Study identifies an endogenous bile acid that alleviates non-alcoholic fatty liver disease

AI-based model indicates chest radiography as a potential biomarker of aging

Meta-analysis reports global prevalence of MAFLD of 38.8% in adults

Sugar-sweetened beverages linked to increased risk of liver cancer and chronic liver disease mortality

Hepatitis C treatment initiation found to be low among Medicaid recipients

Hepatitis C cure still linked to higher mortality rates

Is there an association between alcohol consumption and blood pressure levels?

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Cirrhosis News and Research

Latest Cirrhosis News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in